July 2022
Our highly efficient genome editing technology, CRISPR-SNIPER, was featured in the following article in "Bioradiations"
Our highly efficient genome editing technology, CRISPR-SNIPER, was featured in the following article in "Bioradiations". Title of the article: “Modernizing Gene Editing Detection with Droplet Digital PCR”
Research Project for the Promotion of Innovative Drug Development for Emerging and Re-emerging Infectious Diseases
We are pleased to announce that our proposal has been selected by the Japan Agency for Medical Research and Development (AMED) for the third round of the "Research Project for Promoting Innovative Drug Development for Emerging and Re-emerging Infectious Diseases" in FY2022. The press release can be found here
GenAhead Bio Selected as a Grantee for the Fifth Business Restructuring Subsidy
We are pleased to announce that GenAhead Bio has been selected as a recipient of the "Business Restructuring Subsidy" by the Small and Medium Enterprise Agency. Click here to see the press release.
NEDO's "Research and Development Start-up Support Program" for FY2022
We are pleased to announce that GenAhead Bio has been selected by the New Energy and Industrial Technology Development Organization (NEDO) as a recipient of the "Research and Development Start-up Support Program". Click here for the press release.